Furthermore, CML-iPSCs express higher levels of ALKs than normal iPSCs and are more sensitive to ALK inhibition, resulting in a reduced capacity to self-renew. This evidence concerns the gene ALK and chronic myelogenous leukemia, BCR-ABL1 positive.